Lectin and proteoglycan histochemistry of Merkel cell carcinomas

Experimental Dermatology

Volumn 10, Issue 2, 2001, Pages 100-109

  Sames, K ^a   Schumacher, U ^a   Halata, Z ^a   Van Damme, E J M ^b   Peumans, W J ^b   Asmus, B ^a   Moll, R ^c   Moll, I ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Glycoconjugates; Lectins; Merkel cell carcinoma; Proteoglycans

Indexed keywords

CARBOHYDRATE; CHONDROITIN; CHONDROITIN 6 SULFATE; CYTOKERATIN; FUCOSE; GLUCOSAMINE; GLUCOSE; GLYCAN DERIVATIVE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; LECTIN; MANNOSE; MONOCLONAL ANTIBODY; MUCIN; N ACETYLGALACTOSAMINE; PARAFFIN; PROTEOGLYCAN; SUGAR;

ANTIBODY DETECTION; ARTICLE; BINDING SITE; CANCER GROWTH; CANCER STAGING; CELL DIFFERENTIATION; CLINICAL ARTICLE; EPIDERMIS CELL; EPITHELIUM; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LECTIN BINDING; LECTIN BINDING SITE; MALIGNANT NEOPLASTIC DISEASE; MERKEL CELL TUMOR; NEUROFILAMENT; RESIDUE ANALYSIS; STEM CELL; STROMA CELL; TUMOR CELL;

CARBOHYDRATES; CARCINOMA, MERKEL CELL; GLYCOCONJUGATES; HUMANS; KERATINS; LECTINS; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; NEUROFILAMENT PROTEINS; PHENOTYPE; PROTEOGLYCANS; SKIN NEOPLASMS; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035077345     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0625.2001.010002100.x     Document Type: Article

References (54)

1. Tastzellen und tastkörperchen bei den haustieren und beim menschen
2. Die sinnesorgane der haut und der tiefensensibilität
3. Lectin binding properties of the Merkel cell and other root sheath cells in perinatal rat vibrissae
4. Trabecular carcinoma of the skin
5. Merkel cell carcinoma (neuro-endocrine carcinoma) in uncommon skin location. Immunohistochemical and lectinhistochemical findings
6. The use of antikeratin antibodies in the immunohistochemical distinction between neuroendocrine (Merkel cell) carcinoma of the skin, lymphoma, and oat cell carcinoma
7. Variability of expression and arrangement of cytokeratin and neurofilaments in cutaneous neuroendocrine carcinomas (Merkel cell tumors): Immunohistochemical and biochemical analysis of twelve cases
8. Primary cutaneous neuroendocrine carcinoma (Merkel cell tumor) an adnexal epithelial neoplasm
9. Neuroendocrine (Merkel) cells of the skin: Hyperplasia, dysplasias and neoplasms
10. Molecular characterization of cutaneous neuroendocrine (Merkel cell) carcinoma. Review of the literature and presentation of a caseload
11. Coexpression of neurofilament and keratin proteins in cutaneous neuroendocrine carcinoma cells
12. Intermediate filaments in Merkel cell tumors
13. Cutaneous neuroendocrine carcinoma. Apropos of a case
14. Merkel cell tumor
15. Primary neuroendocrine (Merkel cell) carcinoma of the skin. I. A clinicopathologic and ultrastructural study of 43 cases
16. Ultrastructural lectin histochemical and immunohistological observations on Merkel cell tumors
17. Neuroendocrine carcinoma of the skin (Merkel cell tumor). A clinical case with an ultrastructural and immunohistochemical study
18. A rare case of Merkel's tumor with intestinal metastases
19. Lectin staining of a Merkel cell tumor
20. Merkel cell tumor (neuroendocrine carcinoma). Study of a case with ultrastructural and immunohistochemical findings
21. Lectins and cancer - An old field revisited
22. NG2 proteoglycan-binding peptides target tumor neovasculature
23. Tumor formation dependent on proteoglycan biosynthesis
24. Stable transfection of a glypican-1 antisense construct decreases tumorigenicity in PANC-1 pancreatic carcinoma cells
25. Cell surface chondroitin sulfate proteoglycans in tumor cell adhesion, motility and invasion
26. Altered proteoglycan gene expression and the tumor stroma
27. Glycosaminoglycans: Molecular properties, protein interactions, and role in physiological processes
28. CD44/chondroitin sulfate proteoglycan and alpha2beta1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes
29. Histotopochemical quantification of glycosaminoglycans in melanoma and surrounding epidermis
30. Syndecan-I expression is induced in the stroma of infiltrating breast carcinoma
31. PMA induces shift from chondroitin to heparan sulphate on proteoglycans correlating with fibronectin adhesion of MDS human leukemia cells
32. CD44 expression in Merkel cell carcinoma may correlate with risk of metastasis
33. Actions of heparin that may affect the malignant process
34. A new CD44V3-containing isoform is involved in tumor cell growth and migration during human breast carcinoma progression
35. Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
36. Comparison of the unmasking of lectin receptors by neuraminidase and by enzyme-free buffer alone
37. Combination of the peroxidase antiperoxidase (PAP)- and avidin-biotin-peroxidase complex (ABC)-techniques: An amplification alternative in immunocytochemical staining
38. Mucin-type glycoproteins
39. Stromal accumulation of chondroitin sulphate in mammary tumours of dogs
40. Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer
41. Structural differences of acidic glycosaminoglycans of leukocytes in leukemic states
42. Glycosaminoglycans and proteoglycans in neoplastic tissues and their role in tumor growth and metastasis
43. Ras transformation alters the composition of extracellular matrix proteoglycans in rat fibroblasts
44. Characterization of cell surface-expressed proteochondroitin sulfate of pre-beta Nalm-6 cells and its possible role in laminin adhesion
45. Heparan sulfate proteoglycans play a dual role in regulating fibroblast growth factor-2 mitogenic activity in human breast cancer cells
46. Heparan sulfate proteoglycan expression in human lung-cancer cells
47. Laminin and collagen IV in pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: An immunohistochemical study
48. Laminin-5 as a marker of invasiveness in cervical lesions
49. 32/67-kD laminin receptor expression in human colonic neoplasia elevated transcript levels correlate with the degree of epithelial dysplasia
50. Differential tissular expression and localization of type IV collagen alpha (IV), alpha2 (IV), alpha5 (IV), and alpha6 (IV) chains and their mRNA in normal breast and benign and malignant breast tumors
51. Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma
52. Expression of the alpha1/beta1 laminin receptor suppresses melanoma growth and metastatic potential
53. Presence of a laminin-binding chondroitin sulfate proteoglycan at the cell surface of a human melanoma cell Mel 85
54. Tumor microvessels express the beta-2 chain of laminin. Implication for melanoma metastasis